Annual report of the Australian Gonococcal Surveillance Programme, 1997
DOI:
https://doi.org/10.33321/cdi.1998.22.48Keywords:
antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeaeAbstract
The Australian Gonococcal Surveillance Programme (AGSP) examined 2,817 isolates of Neisseria gonorrhoeae in the period 1 January to 31 December 1997, a number similar to that reported in 1996. The biggest change in incidence of gonococcal disease occurred in New South Wales and Queensland where a 20% rise in the number of isolates was noted. In the latter case this was due to improved surveillance, but in the former represented a real increase. The sites of infection and antibiotic susceptibility patterns varied considerably between regions reflecting considerable differences between rural and urban gonorrhoea in Australia. Strains examined in South Australia, New South Wales and Victoria were predominantly from male patients and rectal and pharyngeal isolates were common. In other centres the male to female ratio was lower and most isolates were from the genital tract. Resistance to the penicillin and quinolone groups of antibiotics were also highest in urban centres, but penicillins remained suitable for use in many parts of rural Australia. Quinolone resistance in gonococci continued to increase. This was particularly so in Sydney where quinolone resistant N. gonorrhoeae (QRNG) accounted for about 15% of all isolates and spread of QRNG was predominantly by local contact. QRNG in other centres continued to be isolated at a lower frequency, mostly from overseas travellers. All isolates remained sensitive to spectinomycin and ceftriaxone. Commun Dis Intell 1998;22:212-216.
Downloads
References
Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868-1873.
Ghys PD, Fransen K, Diablo MO, et al. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosupression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11:F85-F93.
Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-536.
Page-Shafer K, Veuglers PJ, Moss AR, et al. Sexual risk behaviour and risk factors for HIV-1 seroconversion in homosexual men participating in the tricontinental seroconverter study, 1982 - 1994. American Journal of Epidemiology 1997;146;531-542.
Tapsall JW. Surveillance of antibiotic resistance in Neisseria gonorrhoeae and implications for the therapy of gonorrhoea. Int J STD and AIDS 1995;6:233-236.
Philpot CR and Tapsall JW. Single dose therapy of uncomplicated ano-genital gonorrhoea. Med J Aust 1987;146:254-256.
Australian gonococcal surveillance programme. Gonococcal surveillance - Australia (July-September 1981).Commun Dis Intell 1981;25:2-3.
Australian gonococcal surveillance programme. Gonococcal surveillance. Reporting period 1 January to 31 March 1996. Commun Dis Intell 1996;20:499-500.
Australian gonococcal surveillance programme. Gonococcal surveillance. Reporting period 1 April to 30 June 1996. Commun Dis Intell 1996;20:549-550.
Australian gonococcal surveillance programme. Gonococcal surveillance. Reporting period 1 July to 30 September 1996. Commun Dis Intell 1997;21:112.
Australian gonococcal surveillance programme. Penicillin sensitivity of gonococci in Australia: the development of an Australian gonococcal surveillance programme. Br J Vener Dis 1984,60:226-230.
Australian gonococcal surveillance programme. Use of a quality assurance scheme in a long-term multicentric study of antibiotic susceptibility of Neisseria gonorrhoeae. Genitourin Med 1990,66:437-444.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 1998 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
